Medium materiality6/10
Stifel raises Tango Therapeutics price target to $55 from $40
Why it may matterVerify against the original reporting
Bullish analyst revision, with substantial stated upside to the new target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel raised its TNGX price target 37.5% to $55; the target is about 125% above the $24.49 posted price. This is a notable bullish analyst revision, though a price target is an opinion, not a forecast guarantee.
- Stifel raised TNGX’s target from $40 to $55.
- The new target is about 125% above the posted price of $24.49.
Key facts
- 01
Target: $55
- 02
Posted price: $24.49
- 03
Analyst firm: Stifel Nicolaus
- 04
Analyst: Laura Prendergast
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.